<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mechanisms that affect the transcription of the c-myc oncogene take part in the development of B-cell <z:hpo ids='HP_0002664'>neoplasias</z:hpo> such as Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Daudi Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells, which express only the translocated c-myc oncogene, were hybridized with human lymphoblastoid cells, which express the <z:mpath ids='MPATH_458'>normal</z:mpath> c-myc gene; the hybrids were phenotypically lymphoblastoid and expressed both the translocated and the <z:mpath ids='MPATH_458'>normal</z:mpath> c-myc gene </plain></SENT>
<SENT sid="2" pm="."><plain>This result contrasts with the findings that the decapitated c-myc gene, translocated to an immunoglobulin switch mu or alpha region, is transcriptionally silent in lymphoblastoid hybrids </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, there may be at least two distinct enhancer-like elements capable of deregulating c-myc transcription in <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:hpo ids='HP_0001909'>leukemias</z:hpo> with t(8;14) chromosome translocations </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, since the Daudi X lymphoblastoid hybrids express both the translocated and the <z:mpath ids='MPATH_458'>normal</z:mpath> c-myc gene, the c-myc gene product does not autoregulate c-myc transcription </plain></SENT>
</text></document>